Robert Gray Acquires 3,500 Shares of enVVeno Medical Corporation (NASDAQ:NVNO) Stock

enVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray acquired 3,500 shares of enVVeno Medical stock in a transaction dated Tuesday, December 31st. The shares were acquired at an average price of $2.94 per share, with a total value of $10,290.00. Following the completion of the purchase, the director now owns 11,155 shares in the company, valued at approximately $32,795.70. The trade was a 45.72 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

enVVeno Medical Stock Up 1.7 %

Shares of NASDAQ:NVNO traded up $0.05 during midday trading on Thursday, reaching $3.07. The company had a trading volume of 34,365 shares, compared to its average volume of 115,468. enVVeno Medical Corporation has a 1-year low of $2.45 and a 1-year high of $6.97. The stock has a market cap of $53.85 million, a PE ratio of -2.38 and a beta of 1.22. The business’s 50 day moving average price is $3.17 and its 200 day moving average price is $4.26.

enVVeno Medical (NASDAQ:NVNO) last posted its quarterly earnings results on Thursday, October 31st. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.02). On average, research analysts expect that enVVeno Medical Corporation will post -1.3 earnings per share for the current fiscal year.

Institutional Trading of enVVeno Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in NVNO. Hohimer Wealth Management LLC bought a new position in shares of enVVeno Medical in the 3rd quarter valued at about $286,000. Maven Securities LTD acquired a new stake in shares of enVVeno Medical in the third quarter valued at approximately $295,000. Westside Investment Management Inc. boosted its stake in shares of enVVeno Medical by 128.0% during the 3rd quarter. Westside Investment Management Inc. now owns 88,375 shares of the company’s stock worth $297,000 after acquiring an additional 49,613 shares during the period. Corsair Capital Management L.P. acquired a new position in shares of enVVeno Medical during the 3rd quarter worth approximately $390,000. Finally, Geode Capital Management LLC raised its stake in enVVeno Medical by 7.8% in the 3rd quarter. Geode Capital Management LLC now owns 150,676 shares of the company’s stock valued at $506,000 after acquiring an additional 10,902 shares during the period. 34.71% of the stock is owned by institutional investors.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).